Advances in multi-modal non-invasive imaging techniques in the diagnosis and treatment of polypoidal choroidal vasculopathy

Front Med (Lausanne). 2023 Jul 27:10:1221846. doi: 10.3389/fmed.2023.1221846. eCollection 2023.

Abstract

Polypoidal choroidal vasculopathy (PCV) is a disease characterized by subretinal pigment epithelium (RPE) orange-red polypoidal lesions and abnormal branching neovascular networks (BNNs). In recent years, various non-invasive imaging technologies have rapidly developed, especially the emergence of optical coherence tomography angiography (OCTA), multi-spectral imaging, and other technologies, which enable the observation of more features of PCV. In addition, these technologies are faster and less invasive compared to indocyanine green angiography (ICGA). Multi-modal imaging, which combined multiple imaging techniques, provides important references for the diagnosis and treatment of PCV with the assistance of regression models, deep learning, and other algorithms. In this study, we reviewed the non-invasive imaging techniques, multi-modal imaging diagnosis, and multi-scene therapeutic applications of PCV, with the aim of providing a reference for non-invasive multi-modal diagnosis and treatment of PCV.

Keywords: diagnosis; multimodal; non-invasive imaging technology; polypoidal choroidal vasculopathy (PCV); treatment.

Publication types

  • Review

Grants and funding

This study was funded by the Beijing Natural Science Foundation Beijing-Tianjin-Hebei Basic Research Funds: J200007 and National Natural Science Foundation of China: 82271112.